Management of peritoneal metastases – Basic concepts
Paul H. Sugarbaker; pp S2-S11 (Pubmed Abstract, PDF)

The role of cytoreductive surgery and HIPEC in epithelial ovarian cancer
Evgenia Halkia, John Spiliotis; pp S12-S28 (Pubmed Abstract, PDF)

Problems in pelvic cytoreduction – Hostile pelvis
Selman Sokmen; pp S29-S39 (Pubmed Abstract, PDF)

Optimal drugs for HIPEC in different tumors
Eelco de Bree; pp S40-S46 (Pubmed Abstract, PDF)

Management of pseudomyxoma peritonei
Simon A. Fallis, Brendan J. Moran; pp S47-S55 (Pubmed Abstract, PDF)

HIPEC in controversial digestive tumors
Antonios-Apostolos K. Tentes; pp S56-S59 (Pubmed Abstract, PDF)

Digestive fistulas after cytoreductive surgery & HIPEC in peritoneal carcinomatosis
Evgenia Halkia, Elias Efstathiou, Athanassios Rogdakis, Christos Christakis, John Spiliotis; pp S60-S63 (Pubmed Abstract, PDF)

Mapping the location of peritoneal metastases using the peritoneal cancer index and the correlation with overall survival: a retrospective study
John Spiliotis, Evgenia Halkia E, Nausika Kalantzi, Stylianos Giassas, Evangelos Lianos, Elias Efstathiou, Paul H. Sugarbaker; pp S64-S70 (Pubmed Abstract, PDF)

Management of colorectal cancer patients at high risk of peritoneal metastases
Umar Shariff, Charalampos Seretis, Haney Youssef; pp S71-S79 (Pubmed Abstract, PDF)

Cytoreductive surgery and HIPEC for peritoneal carcinomatosis. A review on morbidity and mortality
Evgenia Halkia, Nikolaos Kopanakis, Georgios Nikolaou, John Spiliotis; pp S80-S87 (Pubmed Abstract, PDF)